Alcohol Use Accelerates HIV Disease Progression

Marianna Baum

Carlin Rafie

Shenghan Lai

Sabrina Sales

John Page

Adriana Campa

^{Florida International University, Robert Stempel College of Public Health and Social Work, Miami, Florida.}

^{Johns Hopkins University, Baltimore, Maryland.}

^{University of Miami, Miller School of Medicine, Miami, Florida.}

^{Corresponding author.}

Address correspondence to: Marianna K. Baum, Florida International University, Robert Stempel College of Public Health and Social Work, University Park, Room HLS-1-337, Miami, Florida 33199. E-mail:ude.uif@mmuab

Abstract

The effects of alcohol abuse on HIV disease progression have not been definitively established. A prospective, 30-month, longitudinal study of 231 HIV^{adults included history of alcohol and illicit drug use, adherence to antiretroviral therapy (ART), CD4}^{cell count, and HIV viral load every 6 months. Frequent alcohol users (two or more drinks daily) were 2.91 times (95% CI: 1.23–6.85,}p = 0.015) more likely to present a decline of CD4 to ≤200 cells/μl, independent of baseline CD4^{cell count and HIV viral load, antiretroviral use over time, time since HIV diagnosis, age, and gender. Frequent alcohol users who were not on ART also increased their risk for CD4 cell decline to ≤200 cells/mm}^{(HR = 7.76: 95% CI: 1.2–49.2,}p = 0.03). Combined frequent alcohol use with crack-cocaine showed a significant risk of CD4^{cell decline (HR = 3.57: 95% CI: 1.24–10.31,}p = 0.018). Frequent alcohol intake was associated with higher viral load over time (β = 0.259, p = 0.038). This significance was maintained in those receiving ART (β = 0.384, p = 0.0457), but not in those without ART. Frequent alcohol intake and the combination of frequent alcohol and crack-cocaine accelerate HIV disease progression. The effect of alcohol on CD4^{cell decline appears to be independent of ART, through a direct action on CD4 cells, although alcohol and substance abuse may lead to unmeasured behaviors that promote HIV disease progression. The effect of alcohol abuse on viral load, however, appears to be through reduced adherence to ART.}

Abstract

References

1. WHO Global Status Report on Alcohol. 2004. [Jul 30;2009 ]. . [PubMed]
2. . Reviewed April. 2008. [Apr 30;2009 ]. [PubMed]
3. Phillips SJ. Freedberg KA. Traphagen ET. Horton NJ. Samet JH. Screening for alcohol problems in HIV-infected primary care patients (abstract) J Gen Intern Med. 2001;16:165.[PubMed]
4. Samet JH. Phillips SJ. Horton NJ. Traphagen ET. Freedberg KA. Detecting alcohol problems in HIV-infected patients: Use of the CAGE questionnaire. AIDS Res Hum Retroviruses. 2004;20:151–155.[PubMed]
5. Congliaro J. Gordon AJ. McGinnis KA. Tabeneck L. Justice AC. How harmful is hazardous alcohol use and abuse in HIV infection: Do healthcare providers know who is at risk? J Acquir Immune Defic Syndr. 2003;33:521–525.[PubMed]
6. Kapasi AA. Geeta P. Goenka A, et al. Ethanol promotes T cell apoptosis through the mitochondrial pathway. Immunology. 2003;108:313–320.
7. Barve SS. Kelkar SV. Gobejishvilli L. Joshi-Barve S. McClain CJ. Mechanisms of alcohol-mediated CD4+ T lymphocyte death: Relevance to HIV and HCV pathogenesis. Front Biosci. 2002;7:1689–1696.[PubMed]
8. Balkan J. Vural P. Oztezcan S, et al. Increased LDL+VLDL oxidizability and plasma homocysteine levels in chronic alcoholic patients. J Nutr Sci Vitaminol (Tokyo) 2005;51(2):99–103.[PubMed]
9. Yuksel N. Uzbay IT. Karakilic H. Aki OE. Etik C. Erbas D. Increased serum nitrite/nitrate (NOx) and malondialdehyde (MDA) levels during alcohol withdrawal in alcoholic patients. Pharmacopsychiatry. 2005;38(2):95–96.[PubMed]
10. Kopczynska E. Lampka M. Torlinski L. Ziolkowski M. The level of 8-iso-prostaglandin F2 alpha, 4-hydroxynonenal and malondialdehyde in alcohol dependent men during combined therapy. Psychiatr Pol. 2002;36(2):293–302.[PubMed]
11. Fromenty B. Grimbert S. Mansouri A, et al. Hepatic mitochondrial DNA deletion in alcoholics. Association with microvesicular steatatosis. Gastroenterology. 1995;108:193–200.[PubMed]
12. Mansouri A. Fromenty B. Berson A, et al. Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. J Hepatol. 1997;27:96–102.[PubMed]
13. Mansouri A. Gaou I. De Kerguenec C, et al. An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology. 1999;117:181–190.[PubMed]
14. Cahill A. Cunningham CC. Adachi M, et al. Effects of alcohol and oxidative stress on liver pathology: The role of the mitochondrion. Alcohol Clin Exp Res. 2002;26(6):907–915.
15. Watson RR. Borgs P. Witte M, et al. Alcohol, immunomodulation, and disease. Alcohol Alcohol. 1994;29(2):131–139.[PubMed]
16. Kaslow RA. Blackwelder WC. Ostrow DG, et al. No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1 positive individuals. JAMA. 1989;261:3424–3429.[PubMed]
17. Coates RA. Farewell VT. Raboud J, et al. Cofactors of progression to acquired immunodeficiency syndrome in a cohort of male sexual contacts of men with human immunodeficiency virus disease. Am J Epidemiol. 1990;132(4):717–722.[PubMed]
18. Veugelers PJ. Page KA. Tindall B, et al. Determinants of HIV progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Epidemiol. 1994;140(8):747–758.[PubMed]
19. Penkower L. Dew MA. Kingsley L, et al. Alcohol consumption as a cofactor in the progression of HIV infection and AIDS. Alcohol Alcohol. 1995;12(6):547–552.[PubMed]
20. Wang JY. Liang B. Watson RR. Alcohol consumption alters cytokine release during murine AIDS. Alcohol Alcohol. 1997;14(2):155–159.[PubMed]
21. Bautista AChronic alcohol intoxication attenuates human immunodeficiency virus-1 glycoprotein 120-induced superoxide anion release by isolated Kupffer cells. Alcohol Clin Exp Res. 1998;22(2):474–480.[PubMed][Google Scholar]
22. Watson RR. Odeley OE. Darban HR. Lopez MC. Modification of lymphoid subsets by chronic ethanol consumption in C57BL/6 mice infected with LP-BM4 murine leukemia virus. Alcohol Alcohol. 1992;27(4):417–424.[PubMed]
23. Bermudez LE. Petrofsky M. Kolonoski P. Young LS. An animal model of Mycobacterium avium complex disseminated infection after colonization of intestinal tract. J Infect Dis. 1992;165:75–79.[PubMed]
24. Darban H. Watson RR. Darban JR. Shahbazian LM. Modification of resistance to Streptococcus pneumonia by dietary ethanol, immunization, and murine retroviral infection. Alcohol Clin Exp Res. 1992;16(5):846–851.[PubMed]
25. Bagasra O. Kajdacsy-Balla A. Lischner HW. Effects of alcohol ingestion on in vitro susceptibility of peripheral blood mononuclear cells to infection with HIV and of selected T-cell functions. Alcohol Clin Exp Res. 1989;13(5):636–643.[PubMed]
26. Bagasra O. Kajdacsy-Balla A. Lischner HW. Pomerantz RJ. Alcohol intake increases human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells. J Infect Dis. 1993;167:789–797.[PubMed]
27. Molina PE. McNurlan M. Tathmacher J, et al. Chronic alcohol accentuates nutritional, metabolic, and immune alterations during asymptomatic simian immunodeficiency virus infection. Alcohol Clin Exp Res. 2006;30(12):2065–2078.[PubMed]
28. Bagby GJ. Zhang P. Purcell JE. Didier PJ. Nelson S. Chronic binge ethanol consumption accelerates progression of simian immunodeficiency virus disease. Alcohol Clin Exp Res. 2006;30(10):1781–1790.[PubMed]
29. Molina PE. Lang CH. McNurian M. Bagby GJ. Nelson S. Chronic alcohol accentuates simian acquired immunodeficiency syndrome-associated wasting. Alcohol Clin Exp Res. 2008;32(1):138–147.
30. Howard AA. Arnsten JH. Lo Y, et al. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS. 2002;16(16):2175–2182.[PubMed]
31. Samet JH. Horton NJ. Meli S. Freedberg KA. Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004;28(4):572–577.[PubMed]
32. Miguez MJ. Shor-Posner G. Morales G. Rodriguez A. Burbano X. HIV treatment in drug abusers: Impact of alcohol use. Addict Biol. 2003;8:33–37.[PubMed]
33. Fabris P. Tostitti G. Manfrin V, et al. Does alcohol intake affect highly active antiretroviral therapy (HAART) response in HIV-positive patients? J Acquir Immune Defic Syndr. 2000;25(1):92–93.[PubMed]
34. Palepu A. Horton NJ. Tibbetts N. Meli S. Samet JH. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: The impact of substance abuse treatment. Addiction. 2004;99:361–368.[PubMed]
35. Samet JH. Cheng DM. Libman H. Nunes DP. Alperen JK. Saitz R. Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr. 2007;46(2):194–199.
36. Kapasi AA. Geeta P. Goenka A, et al. Ethanol promotes T cell apoptosis through the mitochondrial pathway. Immunology. 2003;108:313–320.
37. Barve SS. Kelkar SV. Gobejishvilli L. Joshi-Barve S. McClain CJ. Mechanisms of alcohol-mediated CD4+ T lymphocyte death: relevance to HIV and HCV pathogenesis. Front Biosci. 2002;7:1689–1696.[PubMed]
38. Baum MK. Rafie C. Lai S. Sales S. Page B. Campa A. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J Acquir Immune Defic Syndr. 2008;50:93–99.[PubMed]
39. Webber MP. Schonenbaum EE. Gourevitch MN. Buono D. Klein RS. A prospective study of HIV disease progression in female and male drug users. AIDS. 1999;13(2):257–262.[PubMed]
40. Siddiqui NS. Brown LS Jr. Makuch RW. Short-term declines in CD4 levels associated with cocaine use in HIV-1 seropositive, minority injecting drug users. J Natl Med Assoc. 1993;85:293–296.
41. Lucas GM. Gebo KA. Chaisson RE. Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS. 2002;16:767–774.[PubMed]
42. Arnsten JH. Demas PA. Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002;17:377–381.
43. Hinkin CH. Barclay TR. Castellon SA, et al. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behave. 2007;11:185–194.
44. Campa A. Jayaweera DT. Rafie C. Sales S. Page JB. Baum MK. When access to antiretroviral for all is not enough. J Public Admin Manage. 2007;12(3):147–149.[PubMed]
45. Lucas GM. Griswold M. Gebo KA. Keruly J. Chaisson RE. Moore RD. Illicit drug use and HIV-1 disease progression: A longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol. 2006;163:412–420.[PubMed]